GPR120/FFAR4 activation by fatty acid 16:4(n-3) plays a key role in resistance to chemotherapy

被引：0
|
作者：
Houthuijzen, Julia
Oosterom, Ilse
Hudson, Brian
Hirasawa, Akira
Daenen, Laura
McLean, Chelsea
Hansen, Steffen
van Jaarsveld, Marijn
Peeper, Daniel
Sadatmand, Sahar Jafari
Roodhart, Jeanine
van de Lest, Chris
Ulven, Trond
Ishihara, Kenji
Milligan, Graeme
Voest, Emile
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-307
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
307
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Biased signaling and physiological role of free fatty acid receptor GPR120/FFAR4
    Hirasawa, Akira
    Hara, Takafumi
    Iida, Keiko
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S46 - S46
  • [2] Involvement of the Free Fatty Acid Receptor GPR120/FFAR4 in the Development of Nonalcoholic Steatohepatitis
    Nakamoto, Kazuo
    Tokuyama, Shogo
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2019, 139 (09): : 1169 - 1175
  • [3] Alteration of the Glucagon Axis in GPR120 (FFAR4) Knockout Mice A ROLE FOR GPR120 IN GLUCAGON SECRETION
    Suckow, Arthur T.
    Polidori, David
    Yan, Wen
    Chon, Suhyoun
    Ma, Jing Ying
    Leonard, James
    Briscoe, Celia P.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (22) : 15751 - 15763
  • [4] The involvement of adipocyte GPR120/FFAR4 in the progression of nonalcoholic steatohepatitis
    Nakamoto, Kazuo
    Shimada, Koki
    Harada, Shinichi
    Morimoto, Yasuko
    Hirasawa, Akira
    Tokuyama, Shogo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (03) : S121 - S121
  • [5] The molecular mechanism of phytosphingosine binding to FFAR4/GPR120 differs from that of other fatty acids
    Nagasawa, Tomotaka
    Horitani, Masaki
    Kawaguchi, Shin-ichi
    Higashiyama, Shigeki
    Hama, Yoichiro
    Mitsutake, Susumu
    FEBS OPEN BIO, 2021, 11 (11): : 3081 - 3089
  • [6] Activation of the ω-3 fatty acid receptor FFAR4/GPR120 triggers cAMP-dependent mitogenesis and differentiation of preadipocytes via the primary cilium.
    Hilgendorf, K. I.
    Jackson, P. K.
    MOLECULAR BIOLOGY OF THE CELL, 2018, 29 (26) : 152 - 153
  • [7] GPR120/FFAR4: A Potential New Therapeutic Target for Inflammatory Bowel Disease
    Di Petrillo, Amalia
    Kumar, Amit
    Onali, Sara
    Favale, Agnese
    Fantini, Massimo Claudio
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (12) : 1981 - 1989
  • [8] Biological characteristics and agonists of GPR120 (FFAR4) receptor: the present status of research
    Li, Ang
    Li, Yue
    Du, Lupei
    FUTURE MEDICINAL CHEMISTRY, 2015, 7 (11) : 1457 - 1468
  • [9] IL-1β and TNFα inhibit GPR120 (FFAR4) and stimulate GPR84 (EX33) and GPR41 (FFAR3) fatty acid receptor expression in human adipocytes: implications for the anti-inflammatory action of n-3 fatty acids
    Muredda, Laura
    Kepczynska, Malgorzata A.
    Zaibi, Mohamed S.
    Alomar, Suliman Y.
    Trayhurn, Paul
    ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 2018, 124 (02) : 97 - 108
  • [10] Fatty acid 16:4(n-3) stimulates a GPR120-induced signaling cascade in splenic macrophages to promote chemotherapy resistance
    Houthuijzen, Julia M.
    Oosterom, Ilse
    Hudson, Brian D.
    Hirasawa, Akira
    Daenen, Laura G. M.
    McLean, Chelsea M.
    Hansen, Steffen V. F.
    van Jaarsveld, Marijn T. M.
    Peeper, Daniel S.
    Sadatmand, Sahar Jafari
    Roodhart, Jeanine M. L.
    van de Lest, Chris H. A.
    Ulven, Trond
    Ishihara, Kenji
    Milligan, Graeme
    Voest, Emile E.
    FASEB JOURNAL, 2017, 31 (05): : 2195 - 2209
12345